Association of Biliary Anaerobes with Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma

被引:0
|
作者
Nayyar, A. [1 ]
Shrader, H. [2 ]
Williams-Perez, S. M. [1 ]
Suraju, M. O. [1 ]
Miller, A. [1 ]
Coleman, K. [2 ]
Ear, P. [2 ]
Chan, C. H. [1 ]
机构
[1] Univ Iowa Hosp & Clin, Dept Surg, Iowa City, IA 52242 USA
[2] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P154
引用
收藏
页码:S101 / S101
页数:1
相关论文
共 50 条
  • [31] Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
    Schmocker, Ryan K.
    Delitto, Daniel
    Wright, Michael J.
    Ding, Ding
    Cameron, John L.
    Lafaro, Kelly J.
    Burns, William R.
    Wolfgang, Christopher L.
    Burkhart, Richard A.
    He, Jin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) : 405 - 413
  • [32] Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
    Yoshihiro Kurata
    Takayuki Shiraki
    Masanori Ichinose
    Keiichi Kubota
    Yasuo Imai
    [J]. World Journal of Surgical Oncology, 19
  • [33] A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma
    Nishiwada, Satoshi
    Sho, Masayuki
    Cui, Ya
    Yamamura, Kensuke
    Akahori, Takahiro
    Nakagawa, Kenji
    Nagai, Minako
    Nakamura, Kota
    Takagi, Tadataka
    Ikeda, Naoya
    Li, Wei
    Baba, Hideo
    Goel, Ajay
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (03) : 769 - 779
  • [34] Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma
    Zhang, Yun
    Huang, Zi-Xing
    Song, Bin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (22) : 3037 - 3049
  • [35] Response to "Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy"
    Narayanan, Sowmya
    Paniccia, Alessandro
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (06) : 1072 - 1072
  • [36] Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma
    Yun Zhang
    Zi-Xing Huang
    Bin Song
    [J]. World Journal of Gastroenterology, 2021, 27 (22) : 3037 - 3049
  • [37] Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to Chemotherapy
    Shahda, Safi
    Timms, Kirsten M.
    Ibrahim, Ashley A.
    Reid, Julia E.
    Cramer, Harvey M.
    Radovich, Milan
    Ibrahim, Sulfikar
    Allen, Brian
    O'Neil, Bert H.
    [J]. JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 11
  • [38] Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
    Sugawara, Toshitaka
    Rodriguez Franco, Salvador
    Sherman, Samantha
    Kirsch, Michael J.
    Colborn, Kathryn
    Ishida, Jun
    Grandi, Samuele
    Al-Musawi, Mohammed H.
    Gleisner, Ana
    Schulick, Richard D.
    Del Chiaro, Marco
    [J]. JAMA ONCOLOGY, 2023, 9 (03) : 316 - 323
  • [39] Response to Neoadjuvant Chemotherapy in Invasive Intraductal Papillary Mucinous Cystic Neoplasm Compared to De Novo Pancreatic Ductal Adenocarcinoma
    Fogliati, Alessandro
    Zironda, Andrea
    Fiorentini, Guido
    Abdelrahman, Amro M.
    Warner, Susanne
    Thiels, Cornelius A.
    Smoot, Rory L.
    Kendrick, Michael
    Cleary, Sean
    Truty, Mark J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S21 - S22
  • [40] Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma
    Mori, Shozo
    Aoki, Taku
    Sakuraoka, Yuhki
    Shimizu, Takayuki
    Yamaguchi, Takamune
    Park, Kyung-Hwa
    Matsumoto, Takatsugu
    Shiraki, Takayuki
    Iso, Yukihiro
    Kubota, Keiichi
    [J]. PANCREAS, 2021, 50 (05) : 744 - 750